Princeton tissue regeneration company appoints chief medical officer

Princeton-based Derma Sciences Inc., a tissue regeneration company, announced Monday that it has appointed Dr. John Caminis chief medical officer.Caminis, who has extensive experience as a pharmaceutical physician, will report to Edward J. Quilty, the company’s chairman and CEO.

“We are fortunate to be welcoming John Caminis to the Derma Sciences executive management team,” Quilty said in a prepared statement. “He brings exceptional experience and credentials not only in clinical development, but also in fostering relationships with key opinion leaders, submitting regulatory filings and managing contract research organizations.”

Prior to Derma Sciences, Caminis was the senior medical director in the immunology, and later in the bone patient value unit, at UCB, a global pharmaceutical company. Prior to that, he was vice president, clinical development at Warner Chilcott, which is now known as Actavis. Earlier in his career he worked at NPS Pharmaceutical, Novartis Pharmaceuticals and Roche Laboratories.

“This is an exciting time to be joining Derma Sciences as we pursue a tight, patient focused business strategy and are well-positioned for a greater presence in the growing market of advanced wound care,” Caminis said in a prepared statement. “I look forward to joining an impressive team of dedicated associates and executives to add new perspectives to our clinical efforts and to further build our clinical affairs and development capabilities.”

ALSO ON NJBIZ:

Jim Kirkos, head of the Meadowlands chamber, has created master plan to bring region together (Spotlight on Hospitality)

Hospitals learn individual impact of Christie’s charity care budget cuts

Stevens named No. 3 nationally for return on investment; seven N.J. colleges make Top 200